Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
adverse drug reaction
alopecia
amenorrhea
ammonia
anemia
anorexia
anticonvulsants
anticonvulsants, bioavailability
anticonvulsants, blood level determination of
anticonvulsants, cognitive function with
anticonvulsants, compliance
anticonvulsants, discontinuation in seizure-free epileptics
anticonvulsants, dosage
anticonvulsants, effectiveness
anticonvulsants, enzyme inducing
anticonvulsants, hypersensitivity syndrome
anticonvulsants, loading dose
anticonvulsants, mechanism of action of
anticonvulsants, parenteral administration
anticonvulsants, pharmacokinetics
anticonvulsants, rate of administration
anticonvulsants, selection of
anticonvulsants, teratogenicity of
anticonvulsants, untoward effects of
Asperger's syndrome
aspirin
asterixis
attention deficit disorder with hyperactivity
autism
autistic behavior
barbiturate
basal ganglia, lesion, bilateral
behavioral disorder
benzodiazepine
blood dyscrasias, neurologic findings with
bone density
bone loss
bone marrow suppression
caffeine
calcium antagonist
carbamazepine
carnitine deficiency
carnitine deficiency myopathy
cerebral cortical atrophy
cerebrovascular accident
cerebrovascular accident, infancy and childhood
children
chorea
cleft lip
cleft palate
Clinical Pathologic Conference(C.P.C.)
clonazepam
cognition
coma
comorbidities
compliance
complications
confusion
congenital birth defects
congenital deformities
congenital heart disease
congenital malformation
copper deficiency
cost effectiveness
Craniosynostosis
cyclosporine
dementia
dental prostheses
denture cream
developmental disability
developmental evaluation
developmental retardation
differential diagnosis
dilantin
dilantin, factors influencing metabolism of
dilantin, toxicity
drowsiness
drug induced neurologic disorders
drug interactions
drug overdose
drug withdrawal
dysmorphic
dyspraxia
educational status
efficacy
electroencephalogram
embryogenesis
encephalopathy
enzyme, defect
enzyme, induction
enzyme, serum
epilepsia partialis continua
epilepsy referral centers
erythromycin
facial anomalies
falling
fatigue
fetal death
fetal valproate syndrome
fetus
folic acid
gabapentin
gamma amino butyric acid
gastric partitioning
gastritis
gender
gingival hyperplasia
glycine
hair, loss
hallucination
hallucination, visual
headache
hearing loss
heat intolerance
hepatic encephalopathy
hepatic failure
hepatitis
hepatolenticular degeneration, non-Wilsonian
hyperactivity
hyperammonemic encephalopathy
hyperamylasemia
hyperinsulinism
hyperreflexia
hypersensitivity reaction
hyponatremia
hypospadias
hypothermia
hypotonia
iatrogenic neurologic disorders
imbalance
infantile spasm
insulin resistance
intellectual deficit
intelligence quotient
intelligence testing in children
intrauterine
intravenous
jaundice
lamotrigine
leukopenia
level of consciousness, decreased
levetiracetam
liver disease
liver function enzymes
liver transplantation
malabsorption
malabsorption syndrome
malformation, CNS, congenital
menses, irregular
mental status, abnormal
migraine
miosis
misdiagnosis
mortality
movement disorder
movement disorder, drug induced
MRI
MRI, abnormal
MRI, negative
myelopathy
myelopathy, chronic progressive
myoclonic jerks
myopathy
mysoline
naloxone
nausea and vomiting
nerve conduction studies
neural tube defect
neuritis, causes of
neuroendocrinology
neuroleptic
neuropathy
neurotoxin
neutropenia
nutritional deficiency
obesity
ornithine transcarbamylase deficiency
osteoporosis
oxcarbazepine
pain, abdominal
pancreatitis
paresthesias
paresthesias, generalized
Parkinson disease
Parkinson disease, drug induced
Parkinsonism syndrome
petit mal status
phenobarbital
polycystic ovarian syndrome
polydactyly
polypharmacy
pregnancy, anticonvulsants during
pregnancy, neurologic complications in
prenatal
prevention of neurologic disorders
prognosis
progressive infantile poliodystrophy
progressive neurologic disorder
protein C deficiency
psychological testing
psychological testing, children
psychosis
psychosis, acute
quality of life
red cell aplasia
review article
risk factors
risk-benefit assessment
safety
seizure
seizure, children
seizure, classification of
seizure, focal
seizure, intractable
seizure, intractable, treatment of
seizure, medication failure
seizure, minor motor
seizure, paradoxical
seizure, petit mal
seizure, pregnancy
seizure, prognosis in childhood
seizure, psychomotor-temporal lobe
seizure, tonic-clonic
seizure, treatment of
seizure, treatment of, monotherapy
seizure, treatment of, polytherapy
seizure, withdrawal
seizure, women
sensorineural hearing loss
sensory loss
serum glutamic oxaloacetic transaminase
single photon emission computed tomography
skin, lesions in neurologic disorders
sodium valproate
sodium valproate, intravenous
sodium valproate, toxicity
somatosensory evoked potentials
somnolence
spina bifida
spinal cord, lesion of
status epilepticus
status epilepticus, nonconvulsive
status epilepticus, recurrent
teratogenesis
teratogenic drugs
testosterone
testosterone, serum
testosterone, serum, elevated
thermoregulatory disorder
thrombocytopenia
topiramate
treatment of neurologic disorder
tremor
urea-cycle enzymopathies
urinary incontinence
valium
vigabatrin
weakness
weakness, generalized
weight gain
weight loss
wheelchair
zarontin
zinc
Showing articles 1500 to 1550 of 5308 << Previous Next >>

Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis
Ann Neurol 69:75-82, Comi,G.,et al, 2011

Hemicraniectomy in Malignant Middle Cerebral Artery Infarction
Stroke 42:513-516, Staykov,D. &Gupta,R., 2011

Incidence and Predictors of Myocardial Infarction After Transient Ischemic Attack: A Population-Based Study
Stroke 42:935-940, Burns,J.D.,et al, 2011

Bridging Intravenous-Inta-Arterial Rescue Strategy Increases Recanalization and the Likelihood of a Good Outcome in Nonresponder Intravenous Tissue Plasminogen Activator-Treated Patients: A Case-Control Study
Stroke 42:993-997, 880, Rubiera,M.,et al, 2011

Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011

Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:1158-1192, Saposnik,G.,et al, 2011

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011

A Randomized Trial of Prenatal Versus Postnatal Repair of Myelomeningocele
NEJM 364:993-1004, 1076, Adzick,N.S.,et al, 2011

New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011

Focal Status Epilepticus Induced by Hyperbaric Oxygen Therapy
The Neurologist 17:31-33, Seckin,M.,et al, 2011

Xylometazoline Abuse Induced Ischemic Stroke in a Young Adult
The Neurologist 17:41-43, Leupold,D.,et al, 2011

Delirium in the Acute Phase After Stroke
Neurol 76:993-999, Oldenbeuvig,A.W., et al, 2011

Pediatric Sciatic Neuropathies: A 30-year Prospective Study
Neurol 76:976-979, Srinivasan,J.,et al, 2011

Primary Varicella Zoster Infection Associated With Fingolimod Treatment
Neurol 76:1023-1024, Uccelli,A.,et al, 2011

Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011

Motor Vehicle Accidents, Suicides, and Assaults in Epilepsy: A Population-Based Study
Neurol 76:801-806, 770, Kwon,C.,et al, 2011

Recognizing Guillain-Barr� Syndrome in Preschool Children
Neurol 76:807-810, Roodbol,J.,et al, 2011

Rituximab Monotherapy for Patients With Recurrent Primary CNS Lymphoma
Neurol 76:929-930, Batchelor,T.T.,et al, 2011

Clinical and Functional Outcome and Factors Predicting Prognosis in Osmotic Demyelination Syndrome (Central Pontine and/or Extrapontine Myelinolysis) in 25 Patients
JNNP 82:326-331, Kallakatta,R.N.,et al, 2011

Stem Cell Transplantation for Ischemic Stroke
Stroke 42:e33, Boncoraglio,G.B.,et al, 2011

Screening for Fitness to Drive After Stroke: A Systematic Review and Meta-Analysis
Neurol 76:747-756, e35, Devos,H.,et al, 2011

Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects
JAMA 305:1996-2002, Molgaard, D. & Hviid, A., 2011

Evidence-based guideline: Treatment of painful diabetic neuropathy
Neurol 76:1758-1765, Bril,V., et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK
JNNP 82:646-651, Heath, C.A.,et al, 2011

The use of rituximab in myasthenia gravis and Lambert--Eaton myasthenic syndrome
JNNP 82:671-673, Maddison, P.,et al, 2011

Movement Disorders Emergencies Part 1
, Robottom, B.J., et al, 2011

Statin Use Following Intracerebral Hemorrhage
Arch Neurol 68:573-579, Westover, M.B.,et al, 2011

Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011

Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease
Neurol 76:1372-1376, Sone, J.,et al, 2011

Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011

Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011

Efficacy and Safety of Mitoxantrone in Patients with Highly Relapsing Neuromyelitis Optica
Arch Neurol 68:473-479, Kim, S.H.,et al, 2011

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
Neurol 76:1338-1343, Arya, R.,et al, 2011

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011

Clinicopathologic Conference, hemophagocytic lymphohistiocytosis
NEJM 364:1259-1270, Case 10-2011, 2011

Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss
JAMA 305(20):2071-2079,2114, Rauch, S.D.,et al, 2011

Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics
Stroke 42:1771-1774, Tsivgoulis, G.,et al, 2011

Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011

Comparison of IVIg and PLEX in patients with myasthenia gravis
Neurol 76:2017-2023, Barth, D.,et al, 2011

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NEJM 364:22, Wechsler, L.R., 2011

Headache rate and cost of care following lumbar puncture at a single tertiary care hospital
Neurol 77:71-74, Dakka, Y.,et al, 2011

Cerebral Venous Sinus Thrombosis Associated with Cerebral Hemorrhage Is Anticoagulant Treatment Safe?
The Neurologist 17:208-210, Fuentes, B.,et al, 2011

Microbleeds are Associated with Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals
Stroke 42:1867-1871, Bokura, H.,et al, 2011

Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
Stroke 42:1967-1970, Sarikaya, H.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Lancet 377:2013-2022, Bousser, M.G.,et al, 2011

Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age
JNNP 82:712-717, Bhatnagar, P.,et al, 2011



Showing articles 1500 to 1550 of 5308 << Previous Next >>